Chief Financial Officer
Gibb Clarke is a seasoned executive with extensive experience in both health care and medical device markets. As CFO, Gibb is responsible for the financial performance of the company
Gibb was an early member of and Director at the Swedish Neuroscience Institute, a neuroscience center of excellence. Subsequently, Gibb co-founded three additional companies: Pulsar Vascular (acquired by Johnson & Johnson), Blockade Medical (acquired by Balt Medical), and Three Rivers Medical where he recently served as Chief Executive Officer. Throughout his career, Gibb has had significant experience in corporate formation and fundraising, investor relations, device design & development, and commercial operations. Gibb has travelled the globe to work with various commercial partners as well as to train customers on newly approved technologies. Gibb is an avid outdoorsman and holds degrees from Duke University (MBA) and University of Colorado (BA) in political science.
What drew you to work in the diabetes industry?
When I look at healthcare in the US and abroad, I cannot avoid the reality that diabetes, in all forms, is not well managed. There are few conditions with such a large and growing patient population to address where the current standard of patient care is simply not adequate. I see a tremendous opportunity to have an impact on a patient population and the families that live with this condition.
Why did you choose to work at Beta Bionics?
What is the most rewarding part about working at Beta Bionics?
It is impossible to boil this question down to a single sound bite. The passion, the technology, the team, the ability and desire to think differently, our Public Benefit Corporation structure…I could go on. The ultimate reward, however, will be to see the iLet on patients and to transform the lives of those living with type 1 diabetes.